Dr Joydeep is skilled in the diagnosis, treatment and overall management of haematological disorders, such as leukaemia, myeloma and other blood disorders.
He is exceptionally skilled in critical care medicine too.
Dr Joydeep’s primary interest lies in the areas of bone marrow transplantation (BMT), especially mismatched high-end transplants for all conditions, especially acute leukaemias.
He is also very competent in the laboratory diagnostic part of haematological diseases.
Dr Joydeep has played an instrumental role in the development and successful running of many bone marrow transplant departments across the country.
He is also actively involved in research and is working on multiple projects presently. He has also written chapters for several textbooks.
He is a member of the Royal College of Physicians
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer Dominique Farge*, Corinne Frere*, Jean M Connors, Cihan Ay, Alok A Khorana, Andres Munoz, Benjamin Brenner, Ajay Kakkar, Hanadi Rafii, Susan Solymoss, Dialina Brilhante, Manuel Monreal, Henri Bounameaux, Ingrid Pabinger, James Douketis, Joydeep Chakrabartty as a part of the International Initiative on Thrombosis and Cancer (ITAC) advisory panel; Lancet Oncol 2019; Published Online, September 3, 2019 http: //dx.doi.org/10.1016/S1470-2045(19)30336-5
Economic benefits of centrifugal method in therapeutic plasma exchange: experience from private hospitals in India- accepted for oral presentation- International Society of Apheresis, Kyoto , Japan, Oct 2019.
Treosulfan based allogenic conditioning regimes including the use of Generic Treosulfan in Haematological malignancies – poster number 277, BMT Tandem meetings, 2019,
Dikshit N, Sinha R, Maity H, et al. Dose escalation study of bendamustine based conditioning regime (Bace-bendamustine, cytarabine, cyclophosphamide and etoposide) in patients with lymphoma undergoing autologous stem cell transplant. Hematol Transfus Int J. 2017;5(5):294‒297.
BMT TANDEM MEETING 2017(ASBMT) Bendamustine Based Conditioning Regime (BACE-Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) for Patients with Lymphoma Undergoing Autologous Stem Cell Transplant Jain, Neelesh, Amrita Chakrabarti, Rajani Sinha , Nitin Sood, Anil Arabandi, Kasturi Sengupta and Joydeep Chakrabartty
BMT TANDEM MEETING 2017(ASBMT) Safety and efficacy of Darbapoietin alpha in minimizing transfusion requirements in autologous stem cell transplantation. Neelesh Jain, Amrita Chakrabarti, Rajani Sinha , Nitin Sood, Anil Arabandi, Kasturi Sengupta and Joydeep Chakrabartty
Amrita Chakrabarti, Priyanka Samal, Joydeep Chakrabartty, Journal of Clinical and Diagnostic research, 2016 Sep, Vol-10(9), ED04-ED05.
Bilateral combined Retinal Vascular Occlusion: An ocular presentation in Central Nervous system Re-relapse of Non Hodgkins Lymphoma, Amrita Chakrabarti, Priyanka Samal, Joydeep Chakrabartty, Opthalmology Research, 5(4), 1-5, 2016, article number-OR26848.
A rare case of myelofibrosis secondary to juvenile idiopathic arthritis. Jain, N., Sinha, R., Sengupta, J. and Chakrabartty, J. British Journal of Haematology. doi: 10.1111/bjh.14106
Total Marrow Irradiation (TMI) Based T- Replete Myeloablative Haploidentical Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Second Complete Remission: A Single Center Experience of Two Cases Jain, Neelesh, Amitabha Roy and Joydeep Chakrabartty; Biology of Blood and Marrow Transplant , Volume 22 , Issue 3 , S308
Bendamustine Based Conditioning Regime (BACE-Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) for Patients with Lymphoma Undergoing Autologous Stem Cell Transplant Jain, Neelesh, Amrita Chakrabarti, Rajani Sinha , Nitin Sood, Anil Arabandi, Kasturi Sengupta and Joydeep Chakrabartty Biology of Blood and Marrow Transplant , Volume 22 , Issue 3 , S121 - S122
Safety and Efficacy of Low Dose Liposomal Amphotericin B for Prophylaxis of Invasive Fungal Infection in Hematopoietic Stem Cell Transplantation- a Single Center Experience- Joydeep Chakrabartty, Amrita Chakravarti, Kasturi Sengupta, Neelesh Jain, Shilpa Bhartia , Soumya Bhattacharya; Biology of Blood and Marrow transplantation; Volume 21, Issue 2, Supplement, Page S258
Stem cell transplantation for acute myeloid leukaemia in adults, December 2014, Volume 7,Issue 4, pp 227-230 Magazine of European Medical Oncology. – Dr Neelesh Jain, Dr Amrita Chakrabarti, Dr Kasturi Sengupta and Dr Joydeep Chakrabartty
Haematology in Critical care - William Wilkins publication- Chapter-22- M Myeloma.
Received: 11 June 2012 / Accepted: 24 July 2012 - Review article-“SCT - its Importance Today" CML: SCT versus New Drugs Accepted, J Chakrabartty, Dr J Pavlu and Prof Jane Apperley - Magazine of European Medical Oncology
Optimising patient selection for allogeneic stem cell transplantation: prediction of non-relapse mortality and survival 38th Annual Meeting of the European Group for Blood and Marrow TransplantationGeneva, Switzerland, Monday, April 02, 2012; Jiri Pavlu, Katayoun Rezvani, Bhuvan Kishore, Joydeep Chakrabartty, Rajvi Shah, Holger Auner, Dragana Milojkovic, David Marin, Amin Rahemtulla, Donald MacDonald, Edward Kanfer, Francesco Dazzi, John Goldman, Jane Apperley, Richard Szydlo (London, GB)
EBMT 2012: Safety and efficacy of two regimens of high dose liposomal amphotericin B for prophylaxis of invasive fungal infection in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study, Joydeep Chakrabartty, Jiri Pavlu, Lucy Naeve, Maialen Lasa Eguialde , Derville O’Shea, Chrissy Giles, John Goldman, Stephanie Kirschke, Edward Kanfer, Bhuvan Kishore , Donald MacDonald, Dragana Milojkovic, David Marin, Amin Rahemtulla, Eduardo Olavarria, Jane Apperley, and Katayoun Rezvani
EBMT 2012: Cryopreserved Allogeneic Peripheral Blood Stem Cells Result in Outcome Equivalent to Those of Fresh Infusions Enabling Rational Scheduling of Donations; Bhuvan Kishore, John Davis, Katayoun Rezvani, David Marin, Joydeep Chakrabartty, Richard Szydlo, Sandra Loazia, Aristeidis Chaidos, Chrissy Giles, Edward Kanfer, Anastasious Karadimitris, Donald Macdonald, Dragana Milojkovic, Amin Rahemtulla, John Goldman, Jane Apperley, Jiri PavluImperial College Healthcare NHS Trust (London, UK)
ORAL PRESENTATION, ASBMT( American society of blood and marrow transplantation-meeting) San Diego, 01/02/2012 , Impact of Haemochromatosis gene (HFE) polymorphisms and Iron overload on outcome of allogenic stem cell transplantation for Chronic Myeloid Leukaemia, Joydeep Chakrabartty, Rajesh Krishna, Laura G Balderamos, Claire Hunt, Adam Januszewski, Ian Gabriel, David Marin, Jane Apperley, John Goldman, Bhuvan Kishore, Richard Szydlo, Mark Busbridge, Katayoun Rezvani
Abstract - ASH, Pretransplant CRP acting as a predictor for survival in CML patients treated with an allogenic transplant, Jiri Pavlu, Bhuvan Kishore, Joydeep Chakrabartty, Dragana Milojkovich, David Marin, Richard Szydlo, Jane Apperly and John Goldman.
Lymph node Plsmacytoma- A Case report, Bloodmed.com, J.Chakrabartty, U.Ahmed, K.Sengupta, A. Aribandi, V.Sen.
An unusual case of Hodgkin’s Lymphoma obscured by Sarcoid like granulomas; J.Chakrabartty, K. Sengupta, M.Sivakumaran; Tameside Medical Journal, Volume 1, Issue 4, 2008.
Poster Presentation: at the British Society of Haematology Metting 2007- Safety and feasibility of continuous low dose Cytarabine infusion in the non intensive arm of Acute Myeloid Leukemia, J.Chakrabartty, M.Evans, Y.Noble,S.Ward, M.Mangi, S.Bowcock, 2007, 1/5/07
Poster presentation - Hypoglycaemia due to a IgA Binding antibody in a case of IgA kappa Myeloma, MH Mangi, DJ Halsall, R Mainwaring-Burton, S Ward, S Bowcock, J Chakrabatty*, S O'Rahilly .British Society Of Haematologist Meeting - 3/4/06
“Laryngeal Tuberculosis in MDR-TB Presenting as Laryngeal Carcinoma”, S.Mukherjee, A. Sengupta, J.Chakrabartty, Indian Journal of Otolaryngology and Head and Neck Surgery, Vol. 53, 321 (2001).
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.